Grade 11 | 10 Questions | 30 Minutes
* Student information must be exactly the same. Please check for correct spelling, spacing, and capitalization. Otherwise, accurate diagnosis and evaluation will not be possible.
* After 15 minutes, the session will automatically close and your results will be submitted.
In 2012, scientists Jennifer Doudna and Emmanuelle Charpentier developed a tool called CRISPR-Cas9 that changed biology forever. CRISPR allows researchers to edit DNA with remarkable precision, cutting out specific genes and replacing them with new ones. The technology works like a pair of molecular scissors guided by a GPS system. Before CRISPR, editing a single gene could take months and cost thousands of dollars. Now it can be done in days for a fraction of the price. Doudna and Charpentier won the Nobel Prize in Chemistry in 2020 for their discovery.
The medical potential of CRISPR is enormous. Scientists have already used it to treat sickle cell disease, a painful blood disorder that affects about 100,000 Americans. In clinical trials, patients who received CRISPR-based treatments showed dramatic improvement, with some becoming symptom-free for the first time in their lives. Researchers are also exploring CRISPR treatments for cancer, heart disease, and inherited blindness. The technology could eventually eliminate genetic diseases that have caused suffering for thousands of years.
However, CRISPR raises serious ethical concerns. In 2018, Chinese scientist He Jiankui shocked the world by announcing that he had used CRISPR to edit the genes of twin baby girls before they were born. He claimed to have made them resistant to HIV, but the scientific community condemned his actions. The experiment was performed in secret, without proper oversight, and the long-term effects on the children are unknown. He was sentenced to three years in prison. This case highlighted the urgent need for international rules governing gene editing in humans.
The central ethical debate centers on the difference between two types of gene editing. "Somatic" editing changes the DNA of a specific patient and those changes cannot be passed to future generations. Most scientists agree that somatic editing for medical purposes is acceptable. "Germline" editing, however, changes DNA that will be inherited by all future descendants. Critics worry that germline editing could lead to "designer babies," where wealthy parents select traits like intelligence, height, or eye color. This could create new forms of inequality between those who can afford genetic enhancements and those who cannot.
Beyond medicine, CRISPR is being used in agriculture. Scientists have developed disease-resistant crops, longer-lasting fruits, and plants that need less water. These advances could help feed a growing world population, expected to reach 10 billion by 2050. However, some consumers worry about the safety of gene-edited foods, even though current research shows no health risks. The rules for labeling gene-edited foods vary greatly between countries, making international trade more complicated.
As CRISPR technology continues to advance, society must develop clear guidelines for its use. Many scientists support a global agreement that would allow somatic editing for proven medical treatments while placing strict limits on germline editing. Others argue that banning germline editing entirely could prevent important medical breakthroughs. Finding the right balance between scientific progress and ethical responsibility remains one of the greatest challenges of our time.
λΆμ μ€μ λλ€...